-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-lung-cancer.pdf
August 01, 2021 - Overall survival (collect cause of death, if available)
Survival 30-day mortality All deaths within 30 days
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/clinical-care-rapid-review-appendix-c.xlsx
January 01, 2018 - a medical error occurred and compensation is requested, a third meeting is proposed no more than 90 days … a medical error occurred and compensation is requested, a third meeting is proposed no more than 90 days … 1) death, (2) loss of a body part, (3) disability, (4) loss of bodily function (lasting more than 7 days … Disclosure, apology and offer (DA&O) Adams, 2014 Arm 1 Pre-implementation Time to claim resolution, days … Disclosure, apology and offer (DA&O) Adams, 2014 Arm 2 Post-implementation Time to claim resolution, days
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-of-vaccines.pdf
May 25, 2021 - We now also note the
proportion of the studies that
provided short-term follow-up (42
days or less … In
fact, the majority of studies had long-
term follow-up (>42 days) for serious
adverse events, with … Would clarify
why we chose 42 rather than 30 days. … In the
prior report, 42 days was the cut-off
between short- and long-term. … If so, that doesn’t refute
a finding that MMR vaccine can cause
febrile seizures 7-10 days following
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/research-gap-primary-care-summary-table.pdf
March 01, 2022 - disorder:
o Brief behavioral interventions (1–2
encounters):
Motivational interviewing decreases days … months) of buprenorphine/
buprenorphine-naloxone are more
effective than shorter courses (14–28
days … ) to reduce days of opioid use and
achieve abstinence … that increase followup
time and pain assessment beyond 48 hours, and
measure analgesic use in the days
-
effectivehealthcare.ahrq.gov/sites/default/files/brooks_eccs2012.pdf
January 01, 2012 - Brooks_ECCS2012
Slide 1: Addressing
Tensions
When Conventional Wisdom, Clinical Practice
and
Evidence
Collide: Prostate Cancer Screening
Guidelines
Durado
Brooks, M.D., M.P.H.
Director, Prostate
and
Colorectal Cancers
American Cancer…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
July 01, 2012 - i
CER # 17:
Comparative Effectiveness of Medications To Reduce Risk of
Primary Breast Cancer in Women
Original release date:
September 14, 2009
Surveillance Report 1st Assessment: November, 2011
Surveillance Report 2nd Assessment: July, 2012
Key Findings:
• 2 of 6 conclusions for Key Question 1, …
-
effectivehealthcare.ahrq.gov/sites/default/files/norman.pdf
May 29, 2025 - HIGH PLAINS RESEARCH NETWORK
INNOVATIONS CONFERENCE -- HIGH PLAINS RESEARCH NETWORK
SPEAKERS: NED NORMAN,
MEMBER,
HIGH PLAINS RESEARCH NETWORK,
COMMUNITY ADVISORY COUNCIL
SERGIO SANCHEZ,
MEMBER,
HIGH PLAINS RESEARCH NETWORK,
COMMUNITY ADVISORY COUNCIL
…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar-2010_research-protocol.pdf
January 01, 2010 - Real
Time Continuous
Glucose
Monitoring
System
1-7-04 Hypo- and hyperglycemia alerts; up to 21 days
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
January 01, 2013 - be conducted in all patients who received baseline test measurements
on the same day or within few days
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dementia-nursing-home-characteristics_executive.pdf
October 01, 2012 - 1
Comparative Effectiveness Review
Number 79
Comparison of Characteristics of Nursing
Homes and Other Residential Long-Term Care
Settings for People With Dementia
Executive Summary
Background
Dementia is a group of neurological
conditions that lead to gradual decline
in mental function. It is the most
com…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
June 01, 2018 - Intermediate outcomes
Short-term delirium symptoms
Delirium severity
Delirium-free, coma-free days … Intermediate outcomes (short-
term delirium symptoms;
delirium severity; delirium-free,
coma-free days
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
January 01, 2011 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: August 29, 2011
1
Evidence-based Practice Center Systematic Review Protocol
Project Title: Laboratory biomarkers for iron deficiency anemia in late stage chronic
kidney disease
I. Bac…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-257-antenatal-care-evidence-summary.pdf
June 01, 2022 - visit schedules
regarding gestational age at birth (2 RCTs and 2 NRCSs; mean difference [MD] about 0
days
-
effectivehealthcare.ahrq.gov/sites/default/files/transcript_deliberativemethodswebinar.pdf
April 19, 2012 - tend to range from one-day affairs,
although some can be even, you know, a partial day, to
several days … They vary in length from very short
amount of time -- two hours to 2-1/2 days -- their mode --
are
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
December 01, 2015 - The average surgical time was 2
hours, and the average length of hospital stay was 2 days. … The inhaler can be used for up to 15 days if kept clean and dry.80,81 Afrezza
insulin is administered … adverse effects of cataract/glaucoma has not
been taken into consideration, nor the loss of work days … The single injection will likely be an
24
advantage in terms of patient compliance, fewer days
-
effectivehealthcare.ahrq.gov/sites/default/files/manges.pdf
May 29, 2025 - ENVIRONMENTAL PROTECTION AGENCY
INNOVATIONS CONFERENCE -- ENVIRONMENTAL PROTECTION AGENCY
SPEAKER: ELLEN MANGES,
SENIOR ADVISOR, OFFICE OF SOLID WASTE AND EMERGENCY RESPONSE (OSWER)
ENVIRONMENTAL PROTECTION AGENCY (EPA)
MANGES: My name is Ellen Manges. I'm a senior advisor. I…
-
effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
February 01, 2008 - hospital-acquired deep venous thrombosis (DVT) has
been estimated to occur in 40-60% of cases in the 7-14 days … regardless of thromboprophylaxis method, what are
the effects of prolonging thromboprophylaxis for 28 days … or longer compared to
thromboprophylaxis for 7-10 days on VTE [asymptomatic or symptomatic, proximal
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
June 01, 2015 - .39
Analyses demonstrated that overall, patients in the SA+F group reported fewer binge drinking
days … , while patients in control and SA groups reported increased numbers of drinking days. … had significantly greater reductions in total
number of patients with any reported binge drinking days
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
February 01, 2008 - hospital-acquired deep venous thrombosis (DVT) has
been estimated to occur in 40-60% of cases in the 7-14 days … regardless of thromboprophylaxis method, what are
the effects of prolonging thromboprophylaxis for 28 days … or longer compared to
thromboprophylaxis for 7-10 days on VTE [asymptomatic or symptomatic, proximal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
June 13, 2013 - Troponin levels increase within 3 to 4 hours after the onset of damage and remain high
for up to 4 to 7 days … (cTnI) or 10 to 14 days (cTnT). … likely involve a length of followup appropriate
for the diagnosis and treatment of ACS(i.e., hours to days